ClassID:

21046

A61K38/51 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Lyases (4)

Recent Application in this class:
#301
20140322192
2014-10-30

Proteoglycan degrading mutants for treatment of CNS

#302
20140314866
2014-10-23

Materials and methods for modulating immune responses

#303
20140294799
2014-10-02

USE OF COMPOSITIONS HAVING A LOW POLYAMINE CONTENT IN THE PREVENTION OR TREATMENT OF ADVERSE EFFECTS LINKED TO CANCER TREATMENT

#304
20140271601
2014-09-18

CROSSLINKABLE TREHALOSE FOR THE COVALENT INCORPORATION IN HYDROGELS AND METHODS OF USE

#305
20140255469
2014-09-11

Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis

#306
20140255384
2014-09-11

Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin

#307
20140248253
2014-09-04

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CNS INJURIES

#308
20140234286
2014-08-21

Skeletal muscle regeneration promoter

#309
20140212404
2014-07-31

Compositions and Methods for Treating Injuries to the Visual System of a Human

#310
20140212403
2014-07-31

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

#311
20140205583
2014-07-24

USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY

#312
20140193387
2014-07-10

Methods of reducing extravasation of inflammatory cells

#313
20140186433
2014-07-03

Cosmetic treatment system and methods

#314
20140170173
2014-06-19

METHOD OF INDUCING IMMUNE TOLERANCE COMPRISING ADMINISTERING CARBONIC ANHYDRASE I

#315
20140142718
2014-05-22

Flexible tissue matrix and methods for joint repair

#316
20140140977
2014-05-22

Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders

#317
20140086895
2014-03-27

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#318
20140065125
2014-03-06

Pharmaceutical composition for treating depression and method for preparation thereof

#319
20140044771
2014-02-13

Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof

#320
20140037742
2014-02-06

ALGINATE MICROPARTICLES AND METHODS OF USING THE SAME

#321
20140030324
2014-01-30

Compositions and methods for treating or preventing oxalate-related disease

#322
20140010778
2014-01-09

Controlling Pseudomonas aeruginosa persister cells with GM-CSF

#323
20130337549
2013-12-19

Materials and methods for nerve grafting

#324
20130330758
2013-12-12

Method for using an enzyme resistant to high pressures

#325
20130280231
2013-10-24

COMPOSITION FOR PREVENTING OR TREATING OBESITY

#326
20130259851
2013-10-03

USE OF PROKARYOTIC SPHINGOSINE-1-PHOSPHATE LYASES AND OF SPHINGOSINE-1-PHOSPHATE LYASES LACKING A TRANSMEMBRANE DOMAIN FOR TREATING HYPERPROLIFERATIVE AND OTHER DISEASES

#327
20130259848
2013-10-03

Enzyme combinations to reduce brain tissue swelling

#328
20130230509
2013-09-05

Agent for neuropathic pain

#329
20130216515
2013-08-22

Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes

#330
20130209408
2013-08-15

Bacteriophage-containing therapeutic agents

#331
20130136796
2013-05-30

Acellular bioabsorbable tissue regeneration matrices

#332
20130108607
2013-05-02

Methods and compositions for treating oxalate-related conditions

#333
20130101565
2013-04-25

USE OF CARBONIC ANHYDRASE II FOR PRODUCING A DRUG

#334
20130101510
2013-04-25

Methods of treating Parkinson's disease using viral vectors

#335
20130089535
2013-04-11

AGENT FOR REDUCING ACETALDEHYDE IN ORAL CAVITY

#336
20130039898
2013-02-14

COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AND METHODS OF USING COMPOSITIONS THEREOF

#337
20120321648
2012-12-20

USE OF ISLET GLUCOSE-6-PHOSPHATASE RELATED PROTEIN AS A DIAGNOSTIC TOOL AND THERAPEUTIC TARGET FOR AUTOIMMUNE DIABETES

#338
20120308548
2012-12-06

METHIONINE GAMMA LYASE-2-AMINOBUTYRATE DEAMINASE (MEGL-2ABD) AND THERAPEUTIC USES THEREOF

#339
20120308547
2012-12-06

Compositions and methods of using chondroitinase ABCI mutants

#340
20120308545
2012-12-06

Crystallized oxalate decarboxylase and methods of use

#341
20120225930
2012-09-06

METHOD OF TREATING OR RETARDING THE DEVELOPMENT OF BLINDNESS

#342
20120213808
2012-08-23

CARBONIC ANHYDRASE I SERVING AS NOVEL ANTIGEN TO BE USED FOR TREATMENT OF AUTOIMMUNE DISEASES

#343
20120207732
2012-08-16

Compositions and methods for promoting neuronal outgrowth

#344
20120114706
2012-05-10

Endorphin Therapy Compositions and Methods of Use Thereof

#345
20120114611
2012-05-10

Bacteriophage-containing therapeutic agents

#346
20120094900
2012-04-19

Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof

#347
20120071546
2012-03-22

Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use

#348
20120027744
2012-02-02

MODIFIED HEPARINASE III AND METHODS OF SEQUENCING THEREWITH

#349
20110311521
2011-12-22

Novel therapy for anxiety

#350
20110275137
2011-11-10

IMPROVING AGENT FOR NEUROPATHIC PAIN

#351
20110268720
2011-11-03

Formulations of 5-fluorocytosine and uses thereof

#352
20110262413
2011-10-27

Methods of reducing extravasation of inflammatory cells

#353
20110250631
2011-10-13

PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS

#354
20110250251
2011-10-13

Cosmetic Methods And Compositions For Repairing Human Skin

#355
20110207802
2011-08-25

GLUTAMIC ACID DECARBOXYLASE (GAD) BASED DELIVERY SYSTEM

#356
20110207694
2011-08-25

MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM

#357
20110123573
2011-05-26

Methods and compositions for treating phenylketonuria

#358
20110097337
2011-04-28

Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells

#359
20110091576
2011-04-21

Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells

#360
20110082482
2011-04-07

Materials and methods for nerve repair

#361
20110070218
2011-03-24

Methods of treating cancer of the central nervous system

#362
20110052711
2011-03-03

Controlled release multidrug formulations for spinal cord injury

#363
20110052558
2011-03-03

Materials and methods for prevention and treatment of RNA viral diseases

#364
20110020290
2011-01-27

Bacteriophage-containing therapeutic agents

#365
20110014158
2011-01-20

Compositions and methods of using chondroitinase ABCI mutants

#366
20110002978
2011-01-06

ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR CELLS OR TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF

#367
20110002906
2011-01-06

Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes

#368
20100331529
2010-12-30

Methods for increasing protein polyethylene glycol (PEG) conjugation

#369
20100286037
2010-11-11

Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase

#370
20100285080
2010-11-11

Cosmetic treatment system and methods

#371
20100278802
2010-11-04

COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE AND METHODS OF TREATING CANCER USING COMPOSITIONS THEREOF

#372
20100272688
2010-10-28

Method of treating or retarding the development of blindness

#373
20100272686
2010-10-28

Oncolytic virus

#374
20100268336
2010-10-21

Materials and Method for Promotion of Nerve Regeneration

#375
20100260757
2010-10-14

USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY

#376
20100239557
2010-09-23

Compositions and methods of using chondroitinase ABCI mutants

#377
20100172932
2010-07-08

Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes

#378
20100143458
2010-06-10

Glutamic acid decarboxylase (GAD) based delivery system

#379
20100135980
2010-06-03

Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy

#380
20100104537
2010-04-29

Methods of treating Parkinson's disease using viral vectors

#381
20100080845
2010-04-01

Cosmetic Methods And Compositions For Repairing Human Skin

#382
20100080788
2010-04-01

Alginate and alginate lyase compositions and methods of use

#383
20090304666
2009-12-10

CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF

#384
20090300779
2009-12-03

Cancer selective auxotrophs

#385
20090263369
2009-10-22

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

#386
20090252753
2009-10-08

IMMUNOMODULATION FOR AUTOIMMUNE TYPE-2 DIABETES

#387
20090233994
2009-09-17

Glutamic acid decarboxylase (GAD) chimera and methods of use

#388
20090232914
2009-09-17

PHARMACEUTICAL COMPOSITION FOR TREATING DEPRESSION AND METHOD FOR PREPARATION THEREOF

#389
20090202514
2009-08-13

AGENTS FOR IMPROVING CHRONIC OBSTRUCTIVE PULMONARY DISEASES

#390
20090196858
2009-08-06

AMELIORATING AGENT FOR BRAIN DAMAGE

#391
20090104176
2009-04-23

Compositions and methods of using chondroitinase ABCI mutants

#392
20090081635
2009-03-26

Modified heparinase III and methods of sequencing therewith

#393
20090074723
2009-03-19

Method of Treating or Retarding the Development of Blindness

#394
20090060895
2009-03-05

Compositions and methods of using chondroitinase ABCI mutants

#395
20090060892
2009-03-05

AGENTS FOR SUPPRESSING HEPATIC FIBROSIS

#396
20090047309
2009-02-19

COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN

#397
20090047268
2009-02-19

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

#398
20090047265
2009-02-19

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

#399
20090041728
2009-02-12

Proteoglycan degrading mutants for the treatment of CNS

#400
20090028829
2009-01-29

Fusion proteins for the treatment of CNS

#401
20080317810
2008-12-25

Methods and Compositions for Reducing Oxalate Concentrations

#402
20080299536
2008-12-04

Material and Methods for Nerve Grafting

#403
20080292609
2008-11-27

Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies

#404
20080253991
2008-10-16

Anti-T Cell and Autoantigen Treatment of Autoimmune Disease

#405
20080248055
2008-10-09

Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes

#406
20080233099
2008-09-25

Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels

#407
20080233096
2008-09-25

Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels

#408
20080226668
2008-09-18

Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes

#409
20080175832
2008-07-24

Materials and Methods for Prevention and Treatment of RNA Viral Diseases

#410
20080159988
2008-07-03

Materials and methods for treating or preventing oxalate-related disease

#411
20080153740
2008-06-26

Methods for increasing protein polyethylene glycol (PEG) conjugation

#412
20080145352
2008-06-19

Method for promoting axonal re-growth and behavior recovery in spinal cord injury

#413
20080138913
2008-06-12

Composition for Prevention, Treatment, and Diagnosis of Chronic Inflammatory Airway Diseases

#414
20080095718
2008-04-24

METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION

#415
20080089871
2008-04-17

Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells

#416
20080051357
2008-02-28

COMPOSITION FOR ATTENUATING NEUROPATHIC PAIN COMPRISING A RECOMBINANT VENTOR EXPRESSING GAD65

#417
20080039955
2008-02-14

Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells

#418
20080038314
2008-02-14

Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells

#419
20080038246
2008-02-14

Crystallized oxalate decarboxylase and methods of use

#420
20080026065
2008-01-31

Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State

#421
20080025963
2008-01-31

Compositions and methods for the treatment of CNS injuries

#422
20080008661
2008-01-10

METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION

#423
20070274979
2007-11-29

Compositions and methods for promoting neuronal outgrowth

#424
20070254021
2007-11-01

Cosmetic treatment system and methods

#425
20070224182
2007-09-27

Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells

#426
20070207158
2007-09-06

Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof

#427
20070203059
2007-08-30

Targeted Drug-Formaldehyde Conjugates And Methods Of Making And Using The Same

#428
20070202189
2007-08-30

Acellular bioabsorbable tissue regeneration matrices

#429
20070190033
2007-08-16

Bacteriophage-containing therapeutic agents

#430
20070184118
2007-08-09

Compositions and methods for oxalate reduction

#431
20070166367
2007-07-19

Adept or gdept producing acetaldehyde

#432
20070116697
2007-05-24

Nanosphere/microsphere delivery system for the treatment of spinal cord injury

#433
20070104703
2007-05-10

Compositions and methods of using chondroitinase ABCI mutants

#434
20070098807
2007-05-03

Matrices for drug delivery and methods for making and using the same

#435
20070077235
2007-04-05

Composition and method of treating mastitis

#436
20070077228
2007-04-05

Method of treating or retarding the development of blindness

#437
20070031397
2007-02-08

Compositions and methods for enhancing axon regeneration

#438
20070004659
2007-01-04

Method for preventing or delaying the onset of diabetes

#439
20060292135
2006-12-28

Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl

#440
20060275279
2006-12-07

Methods for dissolving cystine stones and reducing cystine in urine

#441
20060275264
2006-12-07

Glutamic acid decarboxylase (GAD) chimera and methods of use

#442
20060233782
2006-10-19

Proteoglycan degrading mutants for the treatment of CNS

#443
20060183713
2006-08-17

Compositions of low molecular weight heparin produced with modified heparinase III

#444
20060182734
2006-08-17

Methods for preparing low molecular weight heparin with modified heparinase III

#445
20060140928
2006-06-29

Use of heparinases to decrease inflammatory response

#446
20060140911
2006-06-29

Bacteriophage for the treatment of bacterial biofilms

#447
20060128946
2006-06-15

Alginases, systems containing alginases and methods of cloning, purifying and/or utilizing alginases

#448
20060121019
2006-06-08

Compositions for treating cystic fibrosis

#449
20060115478
2006-06-01

Methods and compositions for preventing the onset of type 1 diabetes

#450
20060099179
2006-05-11

Glutamic acid decarboxylase (GAD) based delivery system

#451
20060067928
2006-03-30

Heparinase III and methods of specifically cleaving therewith

#452
20060067927
2006-03-30

Methods and compositions related to the modulation of intercellular junctions

#453
20060024284
2006-02-02

Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels

#454
20050250691
2005-11-10

Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes

#455
20050244399
2005-11-03

Method for promoting axonal outgrowth in damaged nerves

#456
20050238617
2005-10-27

Methods for increasing protein polyethylene glycol (PEG) conjugation

#457
20050233402
2005-10-20

Heparinase III HLGAG fragments and uses thereof

#458
20050232901
2005-10-20

Materials and methods for treating or preventing oxalate-related disease

#459
20050209138
2005-09-22

Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes

#460
20050191288
2005-09-01

Use of heparinase to decrease inflammatory responses

#461
20050187173
2005-08-25

Method of delaying the onset of diabetes

#462
20050180955
2005-08-18

Methods of treating parkinson's disease using viral vectors

#463
20050118253
2005-06-02

Systemic delivery of serum stable plasmid lipid particles for cancer therapy

#464
20050118157
2005-06-02

Treatment of central nervous system damage

#465
20050113290
2005-05-26

Method and composition for treating cancer by converting soluble radioactive toxic agents into insoluble radioactive toxic precipitates via the action of non-mammalian enzymes bound to the non-endocytosing receptors of target cells

#466
20050048603
2005-03-03

Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis

#467
20050036981
2005-02-17

USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY

#468
20050031606
2005-02-10

Lyase treatment for

#469
20050025746
2005-02-03

Glutamic acid decarboxylase (GAD) based delivery systems

#470
14954542
2016-06-14

Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith

#471
8485725
2015-01-06

Cloned glutamic acid decarboxylase